Summary
Background Metapopulation models provide platforms for understanding infectious disease dynamics and predicting clinical outcomes across interconnected populations, particularly for large epidemics and pandemics like COVID-19.
Methods We developed a novel metapopulation model for simulating respiratory virus transmission in the North America region, specifically for the 96 states, provinces, and territories of Canada, Mexico and the United States. The model is informed by COVID-19 case data, which are assimilated using the Ensemble Adjustment Kalman filter (EAKF), a Bayesian inference algorithm, and commuting and mobility data, which are used to build and adjust the network and movement across locations on a daily basis.
Findings This model-inference system provides estimates of transmission dynamics, infection rates, and ascertainment rates for each of the 96 locations from January 2020 to March 2021. The results highlight differences in disease dynamics and ascertainment among the three countries.
Interpretation The metapopulation structure enables rapid simulation at large scale, and the data assimilation method makes the system responsive to changes in system dynamics. This model can serve as a versatile platform for modeling other infectious diseases across the North American region.
Funding US Centers for Disease Control and Prevention Contract 75D30122C14289; US NIH Grant AI163023.
Competing Interest Statement
JS and Columbia University disclose partial ownership of SK Analytics. JS discloses consulting for BNI. All other authors declare no competing interests.
Funding Statement
This study was funded by US Centers for Disease Control and Prevention Contract 75D30122C14289; US NIH Grant AI163023.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
"Population and Dwelling Count Highlight Tables, 2016 Census Canada, provinces and territories", Statistics Canada, https://www12.statcan.gc.ca/census-recensement/2016/dp-pd/hlt-fst/pd-pl/Table.cfm?Lang=Eng&T=101&S=50&O=A "Bureau UC. Population", US Census Bureau, https://www.census.gov/topics/population.html "Intercensal Survey 2015", INEGI Mexico, https://en.www.inegi.org.mx/programas/intercensal/2015/#Microdatos "Commuting Flow from Geography of Residence to Geography of Work", Statistics Canada, https://www12.statcan.gc.ca/census-recensement/2016/dp-pd/dt-td/Rp-eng.cfm?TABID=4&LANG=E&A=R&APATH=3&DETAIL=0&DIM=0&FL=A&FREE=0&GC=0&GL=-1&GID=1354564&GK=0&GRP=1&O=D&PID=111333&PRID=10&PTYPE=109445&S=0&SHOWALL=0&SUB=0&Temporal=2017&THEME=125&VID=0&VNAMEE=&VNAMEF=%20(2017)&D1=0&D2=0&D3=0&D4=0&D5=0&D6=0"Number of vehicles travelling between Canada and the United States, Statistics Canada, https://www150.statcan.gc.ca/t1/tbl1/en/tv.action?pid=2410000201 "2011-2015 5-Year ACS Commuting Flows", US Census Bureau, https://www.census.gov/data/tables/2015/demo/metro-micro/commuting-flows-2015.html "COVID-19 Community Mobility Reports", Google, https://www.google.com/covid19/mobility/ "COVID-19 Open Data Google Health", Google, https://health.google.com/covid-19/open-data/data-sources
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors and available online at https://github.com/MatteoPS/NA_SEIR-EAKF
https://github.com/MatteoPS/NA_SEIR-EAKF
https://github.com/MatteoPS/NA_SEIR-EAKF/blob/main/NAE_suppl_material_medRxiv_Jun5.pdf
